3 STAKES IN HYDRAZINE SULFATES HEART, BUT QUESTIONABLE CANCER REMEDIES, LIKE VAMPIRES, ALWAYS RISE AGAIN

被引：5

作者：

HERBERT, V

机构：

来源：

关键词：

D O I：

10.1200/JCO.1994.12.6.1107

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1107 / 1108

页数：2

共 16 条

[1] GOLD J, 1975, ONCOLOGY, V32, P1
[2] HERBERT V, 1986, CANCER, V58, P1930, DOI 10.1002/1097-0142(19861015)58:8+<1930::AID-CNCR2820581422>3.0.CO
[3] 2-X
[4] MOST FREE-RADICAL INJURY IS IRON-RELATED - IT IS PROMOTED BY IRON, HEMIN, HOLOFERRITIN AND VITAMIN-C, AND INHIBITED BY DESFEROXAMINE AND APOFERRITIN
HERBERT, V
SHAW, S
JAYATILLEKE, E
STOPLERKASDAN, T
[J]. STEM CELLS, 1994, 12 (03) : 289 - 303
[5] HERBERT V, 1993, NEW ENGL J MED, V329, P1204
[6] HERBERT V, IN PRESS AM J CLIN N
[7] HERBERT V, 1990, MOUNT SINAI SCH MED
[8] HERBERT V, IN PRESS NUTRITION T
[9] CISPLATIN, VINBLASTINE, AND HYDRAZINE SULFATE IN ADVANCED, NON-SMALL-CELL LUNG-CANCER - A RANDOMIZED PLACEBO-CONTROLLED, DOUBLE-BLIND PHASE-III STUDY OF THE CANCER AND LEUKEMIA GROUP-B
KOSTY, MP
FLEISHMAN, SB
HERNDON, JE
COUGHLIN, K
KORNBLITH, AB
SCALZO, A
MORRIS, JC
MORTIMER, J
GREEN, MR
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (06) : 1113 - 1120
[10] PLACEBO-CONTROLLED TRIAL OF HYDRAZINE SULFATE IN PATIENTS WITH NEWLY-DIAGNOSED NON-SMALL-CELL LUNG-CANCER
LOPRINZI, CL
GOLDBERG, RM
SU, JQ
MAILLIARD, JA
KUROSS, SA
MAKSYMIUK, AW
KUGLER, JW
JETT, JR
GHOSH, C
PFEIFLE, DM
WENDER, DB
BURCH, PA
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (06) : 1126 - 1129